KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Other Non-Current Liabilities (2016 - 2026)

Emergent BioSolutions has reported Other Non-Current Liabilities over the past 17 years, most recently at $41.7 million for Q1 2026.

  • For Q1 2026, Other Non-Current Liabilities rose 17.8% year-over-year to $41.7 million; the TTM value through Mar 2026 reached $41.7 million, up 17.8%, while the annual FY2025 figure was $53.9 million, 37.85% up from the prior year.
  • Other Non-Current Liabilities for Q1 2026 was $41.7 million at Emergent BioSolutions, down from $53.9 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $58.5 million in Q2 2022 and troughed at $4.4 million in Q1 2022.
  • A 5-year average of $35.7 million and a median of $35.8 million in 2024 define the central range for Other Non-Current Liabilities.
  • On a YoY basis, Other Non-Current Liabilities climbed as much as 1070.0% in 2022 and fell as far as 88.42% in 2022.
  • Year by year, Other Non-Current Liabilities stood at $41.5 million in 2022, then plummeted by 30.36% to $28.9 million in 2023, then soared by 35.29% to $39.1 million in 2024, then skyrocketed by 37.85% to $53.9 million in 2025, then decreased by 22.63% to $41.7 million in 2026.
  • Business Quant data shows Other Non-Current Liabilities for EBS at $41.7 million in Q1 2026, $53.9 million in Q4 2025, and $42.6 million in Q3 2025.